Azitra (AZTR) Preferred Dividend Payments (2022 - 2023)

Azitra (AZTR) posted Preferred Dividend Payments of $643267.0 for Q2 2023, down 9.66% on a QoQ basis from $712080.0 in Q1 2023, and down 7.08% year-over-year from $692246.0 in Q2 2022.

Azitra (AZTR) Preferred Dividend Payments (2022 - 2023) Analysis & Trends

Azitra's Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $643267.0 for Q2 2023.

  • Quarterly Preferred Dividend Payments fell 7.08% year-over-year to $643267.0 in Q2 2023, while the trailing twelve-month figure through Mar 2024 was $643267.0 (down 76.93% YoY) and the FY2023 annual result came in at $1.4 million, down 51.05% from the prior year.
  • Preferred Dividend Payments was $643267.0 for Q2 2023 at Azitra, down from $712080.0 in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $712080.0 in Q1 2023 and bottomed at $643267.0 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Nanobiotix 1,785.82 Bn 1,785.76 Bn - -
2 Akari Therapeutics 979.03 Bn 979.03 Bn - -
3 BeOne Medicines 472.98 Bn 468.19 Bn 1.35 Bn -
4 Vertex Pharmaceuticals 123.73 Bn 116.48 Bn 2.59 Bn -
5 Regeneron Pharmaceuticals 71.59 Bn 62.84 Bn 3.31 Bn -
6 Belite Bio 62.00 Bn 62.00 Bn - -
7 Argenx Se 54.67 Bn 49.49 Bn 1.41 Bn -
8 Alnylam Pharmaceuticals 37.96 Bn 34.95 Bn 959.66 Mn -
9 Revolution Medicines 36.08 Bn 36.08 Bn - -
10 Azitra 2.07 Mn 2.07 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 643,267.00
Mar 31, 2023 712,080.00
Dec 31, 2022 692,247.00
Sep 30, 2022 692,246.00
Jun 30, 2022 692,246.00